Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck
- 1 December 1988
- Vol. 62 (11) , 2313-2319
- https://doi.org/10.1002/1097-0142(19881201)62:11<2313::aid-cncr2820621110>3.0.co;2-4
Abstract
We observed a 38% response rate from platinum-based chemotherapy among 34 patients with locally recurrent or disseminated neoplasms from salivary glands or contiguous structures. Adenocarcinoma was the predominant histology. Eleven patients manifested partial response or regression, and two had complete regressions of soft tissue disease. The most durable visceral responses were partial regressions (lung, 11 months; and central nervous system, 34 months). Eleven of the 13 responders showed tumor regression within 3 months of commencing therapy, and the median response duration was 7 months (range 2–34 months). The median survival among all 34 patients was 15 months, and was 18 months among the 13 responders. Hence, a response to treatment did not necessarily confer any long-term survival advantage. Although gastrointestinal toxicities were troublesome with the earlier regimens, contemporary antiemetics (dexamethasone, metoclopramide) have substantially modified these sequelae. Platinum programs may provide useful palliation for selected patients with these neoplasms, but the impact on survival is negligible.This publication has 27 references indexed in Scilit:
- Chemotherapy for salivary gland cancerOtolaryngology -- Head and Neck Surgery, 1986
- Adenoid cystic carcinoma of the salivary gland: Sustained complete response to chemotherapyCancer, 1983
- Chemotherapy of advanced salivary gland neoplasmsCancer, 1982
- Cisplatin Therapy for Adenoid Cystic CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1981
- The management of parotid neoplasmsHead & Neck Surgery, 1981
- Chemotherapy for adenocystic carcinomaCancer, 1980
- Adenoid cystic carcinoma.Biologic behavior in 38 patientsCancer, 1979
- Chemotherapy of malignant major salivary gland neoplasms.A 25-year review of M.D. Anderson hospital experienceCancer, 1977
- Experience with 1,360 primary parotid tumorsThe American Journal of Surgery, 1975
- Infusion of 5-Fluorouracil in Cylindroma TreatmentJAMA Otolaryngology–Head & Neck Surgery, 1964